This is what I've been wracking my brain around recently and unfortunately the quarterly doesn't provide me much information as to how the revenue is produced. Obviously I know there is the white label SAAS and the telemedicine revenue but what are the offers.
My guess is we are only receiving revenue when a user actually uses the platform rather than getting paid for giving a user the access (TDOC).
The reason I believe this is; TDOC (per last estimates) was raking in $18-$20 per subscriber. If we assume the last quarterly's earnings for SOLI are even only 50% of that 7M number then we are generating $0.60 (60 cents) per user annually. That doesn't sound like a monthly access fee but rather a per use type of arrangement. (On the 7M number it's $0.30 per user per year).
There are too many variables at this time. For all we know the contracts we took from KB could be no access fee, and all new contracts are access fees. Maybe this is just to get the ball rolling and become a larger player, offer no access fee and just get % of usage fees. Obviously usage will go up as this becomes a hotter industry and professionals urge patients to use it.
What will make CareClix a massive company overnight is charging a monthly or annual access fee. If you charge each user (7M currently) $1 a month for access to CareClix software/doctors and still charge a co-pay per appointment, your revenue increases by $84M. That $1 is pure profit, 100% margin. The usage is where we have to pay for doctors and will stick to it's ~30% margin.
Hell, if you lose 80% of your clients by charging $1/month, you can still be raking in $16.8M in revenue per year. Based on current expenses we should have no problem turning a net income to pay for expansion.
News 
Market Data 
Discover 
